# Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis

> **NCT00317980** · PHASE4 · COMPLETED · sponsor: **University of Brasilia** · enrollment: 280 (actual)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Meglumine antimoniate
- **DRUG:** Meglumine antimoniate

## Key facts

- **NCT ID:** NCT00317980
- **Lead sponsor:** University of Brasilia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-03
- **Final completion:** 2008-12
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2009-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317980, "Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00317980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*